Martin Gebel

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Venous Thromboembolism

Risk Assessment

Chronic Kidney Disease

Electron Microscopy

Top Venues

Therapeutic innovation & regulatory science

Clinical kidney journal

European heart journal. Cardiovascular pharmacotherapy

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Gebel, Cheryl Renz, Lisa Rodriguez, Arianna Simonetti, Hong Yang, Brian D Edwards, James Matthew Higginson, Nicola Charpentier, Michael Colopy
A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry. Therapeutic innovation & regulatory science (2024)
Martin Gebel, Cheryl Renz, Lisa Rodriguez, Arianna Simonetti, Hong Yang, Brian D Edwards, James Matthew Higginson, Nicola Charpentier, Michael Colopy
A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry. Therapeutic innovation & regulatory science 58 (4) (2024)
Gerasimos S Filippatos, Stefan D Anker, Phyllis August, Andrew J S Coats, James L Januzzi, Boris Mankovsky, Ellen Burgess, Luis M Ruilope, Bertram Pitt, Pantelis A Sarafidis, John R Teerlink, Chris J Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George Bakris, Rajiv Agarwal, null null
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. European heart journal. Cardiovascular pharmacotherapy (2023)
Gerasimos S Filippatos, Stefan D Anker, Phyllis August, Andrew J S Coats, James L Januzzi, Boris Mankovsky, Ellen Burgess, Luis M Ruilope, Bertram Pitt, Pantelis A Sarafidis, John R Teerlink, Chris J Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George Bakris, Rajiv Agarwal
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. European heart journal. Cardiovascular pharmacotherapy 9 (2) (2023)
Rajiv Agarwal, Bertram Pitt, Biff F Palmer, Csaba Pal Kovesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luis M Ruilope, Patrick Rossignol, Ellen Burgess, Roberto Pecoits-Filho, Stefan D Anker, Amer Joseph, Robert Lawatscheck, Daniel Wilson, Martin Gebel, George L Bakris
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clinical kidney journal 16 (2) (2022)
Seung-Kee Min, Ji-Sun Kim, Jang Yong Kim, Ui Jun Park, Taehoon Lee, Jin Mo Kang, Sun-Cheol Park, Won-Il Choi, Ki Hyuk Park, Martin Gebel
Characteristics and Effect of Rivaroxaban on Venous Thromboembolism in Korean Patients Compared to Western Population: A Subgroup Analysis from XALIA(-LEA) Study. Vascular specialist international 38 (2022)
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, Stefan D Anker, Ellen Burgess, Amer Joseph, Peter Kolkhof, Christina Nowack, Martin Gebel, Luis M Ruilope, George L Bakris, null null
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. European heart journal 43 (6) (2022)
Rajiv Agarwal, Bertram Pitt, Biff F Palmer, Csaba Pal Kovesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luis M Ruilope, Patrick Rossignol, Ellen Burgess, Roberto Pecoits-Filho, Stefan D Anker, Amer Joseph, Robert Lawatscheck, Daniel Wilson, Martin Gebel, George L Bakris
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clinical kidney journal 16 (2) (2022)